Zurich, Switzerland | AFP | Swiss pharmaceutical giant Novartis on Tuesday announced $100 million of funding over the next five years for research into new treatments for malaria, a mosquito-borne disease with a devastating impact that killed 445,000 people in 2016. There were some 216 million cases of malaria worldwide in …
Read More »